Newly developed drugs may be susceptible to product obsolescence due to intense competition from new products and less costly generic products
In db/db mice, A 1-42 -treated mice or hTauP301L mice, liraglutide alleviated tau hyperphosphorylation, and prevented dysregulation of Akt and GSK-3 in brain (161, 163, 164)
Any impurities in these starting materials can lead to the formation of deletion sequences or other incorrect products that are difficult to separate from the final peptide
This is not surprising considering that type-2 diabetes is a risk factor for both major and mild CI [2]
They're strategic about WHAT they eat, WHEN they eat, and HOW they manage the side effects
Additionally, GLP-1R expression in the nucleus ACBs may also contribute to this satiety function, more directly in the context of food-seeking motivated behaviors and reward signaling [56]